Skip to content
![Human kidney patient-derived organoids are a promising tool for modeling drug-induced nephrotoxicity and for assessing preclinical toxicity of immunotherapy]()
September 28, 2023
Human kidney patient-derived organoids are a promising tool for modeling drug-induced nephrotoxicity and for assessing preclinical toxicity of immunotherapy
read more
![Optimization of screening conditions using patient-derived organoids for diagnostic purposes]()
May 15, 2023
Optimization of screening conditions using patient-derived organoids for diagnostic purposes
read more
![Patient in the lab: Down-scaling patient-derived organoid screening for diagnostic purposes]()
May 15, 2023
Patient in the lab: Down-scaling patient-derived organoid screening for diagnostic purposes
read more
![Developing a patient-derived organoid biobank, suitable for large-scale drug screenings]()
May 15, 2023
Developing a patient-derived organoid biobank, suitable for large-scale drug screenings
read more
![Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy]()
May 15, 2023
Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy
read more
![Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies]()
May 15, 2023
Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies
read more
![Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies]()
January 16, 2023
Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies
read more
